Peripheral T-Cell Lymphoma Latest Advances

Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative Disorders.

Journal: The American journal of surgical pathology

Published: April 14, 2026

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: March 31, 2026

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

Journal: Indian journal of dermatology

Published: March 26, 2026

A challenging case of facial oedemas revealing a systemic peripheral T-cell lymphoma, not otherwise specified.

Journal: European journal of dermatology : EJD

Published: March 23, 2026

Progression from primary cutaneous CD4+small/medium-sized T-cell lymphoproliferative disorder to peripheral T-cell lymphoma, not otherwise specified: report of a case

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: March 08, 2026

Peripheral T-cell lymphoma-NOS presenting with cavitary lung lesions mimicking invasive aspergillosis.

Journal: BMJ case reports

Published: March 04, 2026

Neutrophil extracellular trap-related genes in PTCL: identification, prognosis and drug interaction prediction via bioinformatics-machine learning.

Journal: Hematology (Amsterdam, Netherlands)

Published: March 03, 2026

Combined oral PI3Kδ inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trial.

Journal: Leukemia & lymphoma

Published: March 03, 2026

Recent progress in T-cell malignancies including adult T-cell leukemia-lymphoma.

Journal: International journal of hematology

Published: February 26, 2026

EBV-positive CD8 + peripheral T-cell lymphoma in the post-transplant setting: case report and review of the literature.

Journal: Journal of hematopathology

Published: February 08, 2026

Adverse events of romidepsin versus tucidinostat for peripheral T-cell lymphoma: a pharmacovigilance study using the Japanese adverse drug event report database.

Journal: Journal of pharmaceutical health care and sciences

Published: January 27, 2026

Angioimmunoblastic T-cell lymphoma with lymphomatous effusion: Diagnostic challenges and cytology-based approaches.

Journal: Histology and histopathology

Published: January 26, 2026

Peripheral T-Cell Lymphoma Latest Advances

Find the Latest Research About Peripheral T-Cell Lymphoma

Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative Disorders.

Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative Disorders.

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

A challenging case of facial oedemas revealing a systemic peripheral T-cell lymphoma, not otherwise specified.

A challenging case of facial oedemas revealing a systemic peripheral T-cell lymphoma, not otherwise specified.

Progression from primary cutaneous CD4+small/medium-sized T-cell lymphoproliferative disorder to peripheral T-cell lymphoma, not otherwise specified: report of a case

Progression from primary cutaneous CD4+small/medium-sized T-cell lymphoproliferative disorder to peripheral T-cell lymphoma, not otherwise specified: report of a case

Peripheral T-cell lymphoma-NOS presenting with cavitary lung lesions mimicking invasive aspergillosis.

Peripheral T-cell lymphoma-NOS presenting with cavitary lung lesions mimicking invasive aspergillosis.

Neutrophil extracellular trap-related genes in PTCL: identification, prognosis and drug interaction prediction via bioinformatics-machine learning.

Neutrophil extracellular trap-related genes in PTCL: identification, prognosis and drug interaction prediction via bioinformatics-machine learning.

Combined oral PI3Kδ inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trial.

Combined oral PI3Kδ inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trial.

Recent progress in T-cell malignancies including adult T-cell leukemia-lymphoma.

Recent progress in T-cell malignancies including adult T-cell leukemia-lymphoma.

EBV-positive CD8 + peripheral T-cell lymphoma in the post-transplant setting: case report and review of the literature.

EBV-positive CD8 + peripheral T-cell lymphoma in the post-transplant setting: case report and review of the literature.

Adverse events of romidepsin versus tucidinostat for peripheral T-cell lymphoma: a pharmacovigilance study using the Japanese adverse drug event report database.

Adverse events of romidepsin versus tucidinostat for peripheral T-cell lymphoma: a pharmacovigilance study using the Japanese adverse drug event report database.

Angioimmunoblastic T-cell lymphoma with lymphomatous effusion: Diagnostic challenges and cytology-based approaches.

Angioimmunoblastic T-cell lymphoma with lymphomatous effusion: Diagnostic challenges and cytology-based approaches.